Related Experiment Video
Updated: Jun 19, 2026

Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding
Published on: September 15, 2010
Interaction Mechanisms of Cold Atmospheric Plasmas with HIV Capsid Protein by Reactive Molecular Dynamics Simulation
Ying Sun1, Yang Chen1, Yuantao Zhang1
1School of Electrical Engineering, Shandong University, Jinan 250061, China.
Abstract:
In recent years, plasma medicine has developed rapidly as a new interdisciplinary discipline. However, the key mechanisms of interactions between cold atmospheric plasma (CAP) and biological tissue are still in the exploration stage. In this study, by introducing the reactive molecular dynamics (MD) simulation, the capsid protein (CA) molecule of HIV was selected as the model to investigate the reaction process upon impact by reactive oxygen species (ROS) from CAP and protein molecules at the atomic level. The simulation results show that ground-state oxygen atoms can abstract hydrogen atoms from protein chains and break hydrogen bonds, leading to the destruction of the disulfide bonds, C-C bonds, and C-N bonds. Furthermore, the generation of alcohol-based groups resulting from the impact of ROS can alter the hydrophobicity of molecules and induce damage to the primary, secondary, and tertiary structures of proteins. The dosage effects on the reaction processes and products induced by CAP are also explored with varying numbers of ROS in the simulation box, and the influences on the broken C-H, N-H, and C-N bonds are discussed. In this study, the computational data suggest that severe damage can be caused to CA upon the impact of ROS by revealing the reaction processes and products.
More Related Videos
07:29Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging
Published on: December 1, 2011
08:33Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015